Lixin Song1, Yousef Qan'ir2, Ting Guan3, Peiran Guo2, Shenmeng Xu2, Ahrang Jung2, Eno Idiagbonya2, Fengyu Song4, Erin Elizabeth Kent5. 1. University of North Carolina at Chapel Hill, School of Nursing, Chapel Hill, North Carolina, USA; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA. Electronic address: lsong@unc.edu. 2. University of North Carolina at Chapel Hill, School of Nursing, Chapel Hill, North Carolina, USA. 3. University of North Carolina at Chapel Hill, School of Social Work, Chapel Hill, North Carolina, USA. 4. West Coast University, General Education, Anaheim, California, USA. 5. University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
Abstract
CONTEXT: Psychosocial behavioral interventions (PBIs) that target patients with cancer and their caregivers face challenges in participant enrollment and retention. OBJECTIVES: 1) Describe characteristics of the patient-caregiver PBI studies; 2) examine participant enrollment and retention rates; 3) identify factors influencing participant enrollment and retention rates; and 4) explore the strategies to promote enrollment and retention rates. METHODS: We identified randomized controlled trials that tested PBIs among adult patients with cancer and caregivers in five electronic databases. We conducted narrative and quantitative analyses to synthesize our findings. RESULTS: Among 55 qualified studies reviewed, most tested the efficacy of PBIs (n = 42) and used two study arms (n = 48). In-person meeting was the most common PBI delivery mode. The primary outcomes included quality of life, physical health, and symptoms. The average of enrollment rates of patient-caregiver dyads was 33% across studies (range 8%-100%; median = 23%). The average retention rate at the end of follow-ups was 69% (range 16%-100%; median = 70%). The number of study arms, recruitment method, type of patient-caregiver relationship, and intervention duration influenced enrollment rates. Study design (efficacy vs. pilot), follow-up duration, mode of delivery, type of relationship, and intervention duration influenced retention rates. Sixteen studies reported retention strategies, including providing money/gift cards upon study completion and/or after follow-up survey, and excluding patients with advanced cancer. CONCLUSION: Researchers need to incorporate effective strategies to optimize enrollment and retention in patient-caregiver PBI trials. Researchers need to report detailed study processes and PBI information to improve research transparency and increase consistency.
CONTEXT: Psychosocial behavioral interventions (PBIs) that target patients with cancer and their caregivers face challenges in participant enrollment and retention. OBJECTIVES: 1) Describe characteristics of the patient-caregiver PBI studies; 2) examine participant enrollment and retention rates; 3) identify factors influencing participant enrollment and retention rates; and 4) explore the strategies to promote enrollment and retention rates. METHODS: We identified randomized controlled trials that tested PBIs among adult patients with cancer and caregivers in five electronic databases. We conducted narrative and quantitative analyses to synthesize our findings. RESULTS: Among 55 qualified studies reviewed, most tested the efficacy of PBIs (n = 42) and used two study arms (n = 48). In-person meeting was the most common PBI delivery mode. The primary outcomes included quality of life, physical health, and symptoms. The average of enrollment rates of patient-caregiver dyads was 33% across studies (range 8%-100%; median = 23%). The average retention rate at the end of follow-ups was 69% (range 16%-100%; median = 70%). The number of study arms, recruitment method, type of patient-caregiver relationship, and intervention duration influenced enrollment rates. Study design (efficacy vs. pilot), follow-up duration, mode of delivery, type of relationship, and intervention duration influenced retention rates. Sixteen studies reported retention strategies, including providing money/gift cards upon study completion and/or after follow-up survey, and excluding patients with advanced cancer. CONCLUSION: Researchers need to incorporate effective strategies to optimize enrollment and retention in patient-caregiver PBI trials. Researchers need to report detailed study processes and PBI information to improve research transparency and increase consistency.
Authors: Frances Marcus Lewis; Kristin A Griffith; Zainab Alzawad; Patricia L Dawson; Ellen H Zahlis; Mary Ellen Shands Journal: Psychooncology Date: 2018-12-28 Impact factor: 3.894
Authors: Annika von Heymann-Horan; Pernille Bidstrup; Mai-Britt Guldin; Per Sjøgren; Elisabeth Anne Wreford Andersen; Hans von der Maase; Jakob Kjellberg; Helle Timm; Christoffer Johansen Journal: Br J Cancer Date: 2018-11-14 Impact factor: 7.640
Authors: Catherine E Mosher; Ekin Secinti; Wei Wu; Deborah A Kashy; Kurt Kroenke; Jonathan B Bricker; Paul R Helft; Anita A Turk; Patrick J Loehrer; Amikar Sehdev; Ahmad A Al-Hader; Victoria L Champion; Shelley A Johns Journal: Palliat Med Date: 2022-05-30 Impact factor: 5.713
Authors: J Nicholas Dionne-Odom; Andres Azuero; Richard A Taylor; Chinara Dosse; Avery C Bechthold; Erin Currie; Rhiannon D Reed; Erin R Harrell; Sally Engler; Deborah B Ejem; Nataliya V Ivankova; Michelle Y Martin; Gabrielle B Rocque; Grant R Williams; Marie A Bakitas Journal: Cancer Date: 2021-12-07 Impact factor: 6.921
Authors: Victoria White; Alice Bastable; Ilana Solo; Seleena Sherwell; Sangeetha Thomas; Rob Blum; Javier Torres; Natalie Maxwell-Davis; Kathy Alexander; Amanda Piper Journal: Support Care Cancer Date: 2022-05-03 Impact factor: 3.359
Authors: J Nicholas Dionne-Odom; Rachel D Wells; Kate Guastaferro; Andres Azuero; Bailey A Hendricks; Erin R Currie; Avery Bechthold; Chinara Dosse; Richard Taylor; Rhiannon D Reed; Erin R Harrell; Shena Gazaway; Sally Engler; Peg McKie; Grant R Williams; Rebecca Sudore; Christine Rini; Abby R Rosenberg; Marie A Bakitas Journal: J Pain Symptom Manage Date: 2021-07-31 Impact factor: 3.612